FDA Says Yaz Users are 74% More at Risk for Blood Clotting

A recently concluded study done by the FDA has shown that, because of the hormone that is most active in the Yaz contraceptive medication, the drug puts users at an increased risk of developing a blood clot by about 74%.
Yaz patients: don't stay at risk for blood clots
Yaz patients: don't stay at risk for blood clots
Spread the Word
Listed Under

* Yaz
* Yaz research
* Yaz Recall
* Yaz Side Effects
* Yaz Attorney

* Legal
* Marketing

* Irvine - California - US

* Services

IRVINE, Calif. - May 9, 2013 - PRLog -- Irvine, CA—“On October 27, 2011, the FDA released its own study of more than 800,000 women. Although it reached similar results, the FDA study quantified that drugs like Yaz containing drospirenone could actually increase the risk of blood clots by as much as 74%.  With such high occurrence rates and estimates that more than 80 million women have taken these birth control drugs, it came as little surprise when The Institute for Safe Medicine Practices reported that Yaz and Yasmin ranked second highest in 2011 for the number of complications reported to the FDA.”  This excerpt from a well known user report and drug information website contains startling facts about Yaz, a drug used for female birth control and produced by Bayer Pharmaceuticals.  The FDA (U.S. Food and Drug Administration), according to this website and other prominent sites, has finished several studies on Yaz, showing that because the drug contains drospirenone—a dangerous synthetic progestin—users are at a 74% increased risk for getting a blood clot.

Respected medical journals all around the world are reporting on drospirenone containing medications like Yaz upon the conclusion of studies done on them—all of these studies are finding a disturbingly strong link between Yaz and blooding clotting: “One 10-year study tracked blood clot rates in 15- to 49-year-old Danish women with no history of cardiovascular disease. The study found that women taking pills containing…drospirenone were at higher risk for blood clots than women taking pills containing levonorgestrel, one of the oldest synthetic progestins.  A second study of more than 3,200 Dutch women found that compared with women who did not use birth control, women taking…drospirenone had a 6.3 times greater risk (for developing a blood clot.”  Obviously, this information is upsetting because of the high levels of reported risk, which can lead to not only blood clotting, but DVT (Deep Vein Thrombosis), pulmonary embolism, and heart attack as well.

The law offices of Bond & Taylor deeply sympathize with all people who have taken Yaz and been afterwards injured.  As a response to this widespread drug disaster, Bond & Taylor is giving out free legal counsel and advice to all women who have used the Yaz birth control medication.  These individuals are advised to visit Bond & Taylor’s website at http://www.bondtaylorlaw.com/ and/or to call the phone number below in order to speak with a kind and caring representative of Bond & Taylor who is able to provide more information about the process of filing a lawsuit against the Yaz manufacturer, Bayer Pharmaceuticals.  Bond & Taylor is an advocacy first legal team, meaning that those current or former Yaz users who become clients never pay anything—including court fees and filing costs—except for a small contingency fee upon the successful settlement or trial conclusion.

Bond & Taylor, LLC
Candice McGurk, Managing Attorney
1 (800) 471-0314
Posted By:***@webshark360.com Email Verified
Phone:(949) 988-7100
Tags:Yaz, Yaz research, Yaz Recall, Yaz Side Effects, Yaz Attorney
Industry:Legal, Marketing
Location:Irvine - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Webshark 360 News
Most Viewed
Daily News

Like PRLog?
Click to Share